Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.26 USD | +1.00% | +1.35% | -8.79% |
Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
Apr. 22 | Pfizer's Emblaveo Receives European Commission Marketing Approval | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.79% | 149B | |
+25.46% | 659B | |
+26.69% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.51% | 215B | |
+7.53% | 210B | |
-6.30% | 200B | |
-5.59% | 146B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer : SVB Leerink Adjusts Price Target on Pfizer to $49 From $47, Maintains Market Perform Rating